The Gross Margin of Nabriva Therapeutics PLC (NBRV) is 22.62%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2022-12-31 | 22.62% |
| 2021-12-31 | 54.50% |
| 2020-12-31 | 84.69% |
| 2019-12-31 | 99.26% |
| 2018-12-31 | -464.35% |
| 2017-12-31 | -296.82% |
| 2016-12-31 | 26.67% |